It is anticipated that the inflammatory disorders of the vaginal and vulval inflammatory diseases treatment market would grow from US$ 2.8 billion in fiscal year 2022 to US$ 2.96 billion in fiscal year 2023. Between 2023 and 2033, the global market is anticipated to expand at a 5.8% CAGR, peaking at US$ 5.21 billion by the …
Category Archives: Healthcare Trends
Transfusion Dependent Thalassaemia Management Market Seeks 6% CAGR Growth Through 2033 Amid Rising Demand | Future market Insights,Inc.
The global Transfusion Dependent Thalassaemia Management Market is anticipated to reach a market value of US$ 10 Million in 2023 and to reach US$ 17.91 Million by registering a CAGR of 6% from 2023 to 2033. In the historical period from 2018 to 2022, the market for Transfusion Dependent Thalassaemia Management experienced a 4% CAGR. Studies state …
PPG Biosensors Market Sets Sights on US$ 1.9 Billion Valuation by 2033| Future Market Insights,Inc.
According to the newly released PPG Biosensors Market study report from Future Market Insights, the global market size of PPG biosensors in 2022 will be US$ 473 Million. The market is expected to be worth US$ 1.9 billion by 2033, growing at a CAGR of 15.2% between 2023 and 2033. With a CAGR of more than 17.1 …
Fucosidosis Therapeutics Market Targets US$ 17.91 Million by 2033 with a 6% CAGR | Future Market Insights,Inc.
With a CAGR of 6% from 2023 to 2033, the global Fucosidosis Therapeutics Market sales is anticipated to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033. The Fucosidosis Therapeutics market increased at a 4% CAGR between 2018 and 2022. According to studies, fucosidosis is a rare autosomal recessive lysosomal storage illness marked …
Drug Eruptions Treatment Market Projected to Reach US$ 7.1 Billion by 2033 | Future market Insights,Inc.
In fiscal year 2023, the global Drug Eruptions Treatment Market revenue is expected to be worth US$ 3.89 billion, up from US$ 3.66 billion in fiscal year 2022. The global market is expected to grow at a 6.2% CAGR from 2023 to 2033, reaching US$ 7.1 billion by the end of that year. A drug rash is …
Donohue Syndrome Treatment Market Reaches US$ 25 Billion by 2033
According to a recent FMI analysis, the global Donohue Syndrome Treatment Market Demand is expected to grow at a 4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 25 billion by the end of the assessment period. Donohue syndrome, also known as leprechaunism, is an extremely rare and severe genetic disorder …
Continue reading “Donohue Syndrome Treatment Market Reaches US$ 25 Billion by 2033”
Coxsackievirus: Treatment Market Valued at US$ 5.5 Billion in 2023, Poised for 8.2% CAGR Growth
The global coxsackievirus infections treatment market is currently valued at US$ 5.5 Billion in 2023 and is anticipated to expand at a CAGR of 8.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 12.1 Billion by 2033. Major factors driving the global coxsackievirus diagnostics market are increase in incidence of coxsackievirus infections, surge …
Brachytherapy Market expansion is spearheaded by Applicators and after loaders, aiming for an 8.3% CAGR by 2032
The Brachytherapy Market refers to the market for a medical technique called brachytherapy, which is a form of radiation therapy used in the treatment of cancer. Brachytherapy involves the placement of radioactive sources directly into or near the tumor, delivering a high dose of radiation to the cancer cells while minimizing radiation exposure to surrounding …
Lipid Nanoparticles Industry set to expand with a 13.6% CAGR from 2023 to 2033, according to FMI
It is projected that the global Lipid Nanoparticles Industry size will be valued at US$ 887.2 million in 2023. The market is expected to expand at a CAGR of 13.6% between 2023 and 2033, reaching approximately US$ 3,175.5 million by 2033, due to rising health concerns about dietary supplements as a result of Covid-19 and increasing dietary …
Bovine Lactoferrin Industry is set to experience a robust 15.8% CAGR by 2033, heralding a healthier future | FMI
The Bovine Lactoferrin Industry refers to the global industry involved in the production, distribution, and sale of bovine lactoferrin, a protein derived from cow’s milk. Bovine lactoferrin is known for its various health benefits and is widely used in the pharmaceutical, food, and nutritional supplement industries. Bovine lactoferrin offers several advantages, including its antimicrobial, immune-boosting, …